US20100316664A1 - Agent For Growing Fibroblasts - Google Patents

Agent For Growing Fibroblasts Download PDF

Info

Publication number
US20100316664A1
US20100316664A1 US12/867,771 US86777109A US2010316664A1 US 20100316664 A1 US20100316664 A1 US 20100316664A1 US 86777109 A US86777109 A US 86777109A US 2010316664 A1 US2010316664 A1 US 2010316664A1
Authority
US
United States
Prior art keywords
fibroblasts
agent
skin
extract
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/867,771
Other languages
English (en)
Inventor
Masato Iino
Satoshi Amano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Assigned to SHISEIDO COMPANY, LTD. reassignment SHISEIDO COMPANY, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMANO, SATOSHI, IINO, MASATO
Publication of US20100316664A1 publication Critical patent/US20100316664A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Definitions

  • This invention relates to an agent for growing fibroblasts.
  • This invention particularly relates to an agent for growing fibroblasts capable of promoting the growth of aged fibroblasts.
  • This invention also relates to an external preparation for skin, which preparation contains the agent for growing fibroblasts.
  • the skin is principally classified into three layers, i.e., the epidermis, the derma, and the hypodermic tissue. Of the three layers, the derma is markedly important for keeping the skin structure.
  • the derma is a binding tissue having a structure in which, principally, fibroblasts, collagen fibers, elastic fibers (elastin), and the like, spread in a composite, three-dimensional pattern.
  • the proteins, such as collagen, which constitute the fibers, are produced by the fibroblasts.
  • the fibroblasts keep the balance of synthesis and decomposition of the proteins and keep the condition of the binding tissue. The strength, the stretchability, and the elasticity of the skin are thereby maintained.
  • the binding tissue of the derma decreases, and the functions which the skin keeps originally, such as contractibility, flexibility, and moisturizing character, become weak.
  • various troubles of the skin such as the occurrence of wrinkles and sagging, and the lowering of suppleness and elasticity, occur.
  • the important factors for the skin aging symptoms as described above are the decrease of the number of the fibroblasts of the derma of the skin, the lowering of the functions of the fibroblasts of the derma of the skin, and the decrease of matrix fibers which are produced by the fibroblasts. Therefore, in order for an anti-aging external preparation for skin having an action of preventing and improving skin aging to be obtained, attempts have heretofore been made to search and blend a constituent having a function of promoting the growth of fibroblasts.
  • a yeast extract has a collagen production promoting action (in patent literature 3), a moisturizing effect (in patent literature 4), a cell activating action, and a hyaluronic acid production promoting action (in patent literature 5).
  • the yeast extract is blended in external preparations for skin, such as the cosmetic preparations.
  • a safflower extract has a vitiated blood improving action.
  • the safflower extract is used for improvement of the cold of the whole body (improvement of blood flow at skin distal areas), the improvement of a pimple, and treatment for atopic dermatitis (in patent literature 6).
  • the safflower extract has elastase inhibitory activity (in patent literature 7).
  • the safflower extract is blended in an anti-aging external preparation for skin, or the like, for obtaining a cell activating action (in patent literature 8).
  • the primary object of the present invention is to provide an agent for growing fibroblasts, which is capable of enhancing growth of not only young fibroblasts but also aged fibroblasts, and which is safe and effective.
  • the inventors have found that, in cases where a yeast extract and a safflower extract are used in combination, cell growth is capable of being promoted markedly even with respect to aged fibroblasts.
  • the present invention is based upon the findings described above.
  • each of the yeast extract and the safflower extract has heretofore been known as a cell activating agent.
  • the cellular proliferative potential of which has become decreased with age.
  • the growth of the aged fibroblasts is capable of being enhanced synergistically.
  • the present invention provides an agent for growing fibroblasts, containing a yeast extract and a safflower extract as effective constituents.
  • the present invention also provides a method of growing fibroblasts, wherein a yeast extract and a safflower extract are used.
  • the present invention further provides an anti-aging agent for skin, containing a yeast extract and a safflower extract as effective constituents.
  • aged fibroblasts means the fibroblasts which have suffered from the decreasing in functions, such as the cellular proliferative potential and the extracellular matrix producing capability, with age or due to adverse effects of ultraviolet light, active oxygen, and the like.
  • the yeast extract should preferably be the yeast extract having been prepared from the yeast, which has been cultured in a nutrient culture medium containing glycosaminoglycan and has been subjected to ultraviolet light irradiation processing and/or hydrogen peroxide processing. It has been found that, in cases where the yeast is cultured in the glycosaminoglycan-containing nutrient culture medium in the presence of a stress due to ultraviolet light and/or hydrogen peroxide, a cell protecting constituent is produced. By use of the yeast extract having been prepared from the cultured yeast as described above, the growth of the fibroblasts is enhanced more effectively.
  • the present invention still further provides an external preparation for skin, containing the agent for growing fibroblasts in accordance with the present invention.
  • the agent for growing fibroblasts in accordance with the present invention is blended in the external preparation for skin, such as a cosmetic preparation, it is possible to prevent or improve the decrease of the function and number of the fibroblasts in the binding tissue of the derma with age, and the like, and to effectively prevent or improve the symptoms of the skin aging, such as the occurrence of the wrinkles and the sagging, and the lowering of the suppleness and the elasticity.
  • the large effect of promoting the cell growth is obtained with respect to not only the young fibroblasts but also the aged fibroblasts. Also, the fibroblasts in the derma of the aged skin are multiplied, and the suppleness and the elasticity of the skin are enhanced in a safe and effective manner, such that no adverse effect may occur on the skin.
  • the agent for growing fibroblasts in accordance with the present invention or the external preparation for skin, which contains the agent for growing fibroblasts in accordance with the present invention to the skin, the symptoms of the skin aging, such as the occurrence of wrinkles and sagging, and the lowering of the suppleness and the elasticity, are prevented or improved effectively.
  • FIG. 1 is a graph showing an effect of a combination of a safflower extract and a yeast extract upon growth of young or aged fibroblasts.
  • the agent for growing fibroblasts, or the like, in accordance with the present invention contains the yeast extract and the safflower extract as the effective constituents.
  • the yeast extract it is possible to employ an extract of the yeast with a polar solvent; a yeast decomposition product, which results from bacteriolysis of the yeast with self-digestion, acidolysis, enzymatic hydrolysis, or the like, and which has been subjected to filtration; or an extract obtained from processing, in which the yeast decomposition product as described above is dried and then subjected to extraction with a polar solvent, or the like.
  • an Ascomycetes yeast e.g., a yeast of a genus belonging to an Endomycetaceae family, such as an Eremascus genus or an Endomyces genus; a yeast of a genus belonging to a Saccharomycetaceae family, such as a Schizosaccharomyces genus, a Nadsonia genus, a Saccharomycodes genus, a Hanseniaspora genus, a Wickerhamia genus, a Saccharomyces genus, a Kluyveromyces genus, a Lodderomyces genus, a Wingea genus, an Endomycopsis genus, a Pichia genus, a Hansenula genus, a Pachysolen genus, a Citeromyces genus,
  • an Ascomycetes yeast e.g., a yeast of a
  • the yeast extract should preferably be prepared from a fungus body, such as the yeast of the Saccharomyces genus, e.g., a beer yeast, a sake yeast, or a baker's yeast.
  • a yeast extract commercially available under the trade name of “Yeast Extract.”
  • a solvent for the extraction it is possible to employ water; physiological saline; a phosphate buffer; phosphate buffered saline; a polar organic solvent, e.g., a lower alcohol, such as methanol, ethanol, propanol, or isopropanol; a polyhydric alcohol, such as 1,3-butylene glycol, propylene glycol, dipropylene glycol, or glycerol; an ether, such as diethyl ether or dipropyl ether; an ester, such as ethyl acetate or butyl acetate; or a ketone, such as acetone or ethyl methyl ketone.
  • a lower alcohol such as methanol, ethanol, propanol, or isopropanol
  • a polyhydric alcohol such as 1,3-butylene glycol, propylene glycol, dipropylene glycol, or glycerol
  • an ether such as die
  • the yeast or the yeast decomposition product may be subjected to freeze-drying and/or pulverizing and may then be subjected to the extraction. Also, homogenizing may be performed in the extraction solvent, and ultrasonic crushing may be performed.
  • the extraction temperature ordinarily falls within the range of approximately 0° C. to a temperature equal to at most the boiling temperature of the solvent. Also, the extraction time varies in accordance with the kind of the extraction solvent and the extraction temperature and ordinarily falls within the range of approximately one hour to approximately five days.
  • the yeast extract it is possible to use preferably the yeast extract having been prepared from the yeast, which has been cultured in the nutrient culture medium containing glycosaminoglycan and has been subjected to the ultraviolet light irradiation processing and/or the hydrogen peroxide processing. It has been found that, in cases where the yeast is cultured in the presence of a stress due to ultraviolet light and/or hydrogen peroxide, the cell protecting constituent, which protects the cells from the stress, is produced. Further, in such cases, by the addition of nutrient peptone, glycosaminoglycan, or the like, to the culture medium, the response to the stress is enhanced.
  • a process for producing the yeast extract, or the like is described in, for example, U.S.
  • the yeast extract may be prepared with a process, wherein a Saccharomyces cerevisiae yeast, which is one kind of the baker's yeast, is cultured in a nutrient culture medium having been added with non-animal derived glycosaminoglycan, wherein a stress is loaded to the cultured yeast by the addition of hydrogen peroxide in a sublethal proportion, e.g.
  • the cultured yeast having thus been obtained is solubilized by self-digestion, acidolysis, or the like, and is then subjected to drying, extraction with water, filtration, and the like.
  • a sublethal dose of the ultraviolet light e.g., UVA/UVB irradiation with an intensity of 31.5 mJ/cm 2
  • a yeast extract having been prepared from a yeast, which has been cultured in a culture medium containing non-animal derived glycosaminoglycan and has been subjected to the ultraviolet light irradiation processing and the hydrogen peroxide processing is commercially supplied under the trade name “Biodyne EMPP (trademark)” by Arch Personal Care Products L. P.
  • the safflower extract may be prepared by performing solvent extraction of a safflower ( Carthamus tinctorius L.). It is possible to use each of parts of the safflower, such as a flower, a leaf, a stalk, a root stalk, and a root, or the whole of the safflower. It is preferable to use the flower of the safflower used as a crude drug “Kouka (Carthami Flos.)”
  • the safflower may be subjected to the extracting operation in a crude state.
  • the extraction should preferably be performed after the processing, such as slicing, drying, or pulverizing, has been performed.
  • the extraction is performed by dipping in the extraction solvent.
  • stirring may be performed, or the homogenizing may be performed in the extraction solvent.
  • the extraction temperature ordinarily falls within the range of approximately 5° C. to a temperature equal to at most the boiling temperature of the solvent.
  • the extraction time ordinarily falls within the range of approximately four hours to approximately 14 days.
  • the extraction solvent it is possible to employ water; physiological saline; a phosphate buffer; phosphate buffered saline; a polar organic solvent, e.g., a lower alcohol, such as methanol, ethanol, propanol, isopropanol, or butanol; a polyhydric alcohol, such as 1,3-butylene glycol, propylene glycol, dipropylene glycol, 1, 2-pentanediol, or glycerol; an ether, such as ethyl ether or propyl ether; an ester, such as ethyl acetate or butyl acetate; or a ketone, such as acetone or ethyl methyl ketone; or a mixed solvent containing at least two kinds of the solvents selected from the above-enumerated solvents.
  • a polar organic solvent e.g., a lower alcohol, such as methanol, ethanol, propanol,
  • a safflower extract having been obtained from the processing wherein the flower of the safflower is subjected to the extraction with 50% 1,3-butylene glycol and the filtration.
  • an extract commercially available as the safflower extract may be used in the present invention.
  • the yeast extract and the safflower extract may be employed directly.
  • the agent for growing fibroblasts, or the like, in accordance with the present invention may be used in an arbitrary form, such as a solution, a suspension, an emulsion, a cream agent, an ointment agent, a gel agent, or a powdered medicine, by the addition of an arbitrary appropriate auxiliary, such as a carrier, a diluting agent, a stabilizing agent, a buffer agent, a pH adjusting agent, or a solvent.
  • the agent for growing fibroblasts, or the like, in accordance with the present invention may be encapsulated in a liposome, a micro-capsule, or the like. Further, besides the essential constituents described above, the agent for growing fibroblasts, or the like, in accordance with the present invention may be added with a stabilizing agent and an absorption promoting agent, such as an anti-oxidizing agent, an antiseptic agent, or a ultraviolet light absorbing agent, such that the effects of the present invention may not be affected adversely.
  • a stabilizing agent and an absorption promoting agent such as an anti-oxidizing agent, an antiseptic agent, or a ultraviolet light absorbing agent
  • the agent for growing fibroblasts, or the like, in accordance with the present invention may be contained in an external preparation base, or the like, and the external preparation for skin may thereby be prepared.
  • the blending proportion of each of the yeast extract and the safflower extract in the external preparation for skin should preferably fall within the range of 0.00001% by mass to 10% by mass, should more preferably fall within the range of 0.001% by mass to 5% by mass, and should most preferably fall within the range of 0.005% by mass to 1% by mass.
  • the blending proportion of the safflower extract with respect to the total mass of the external preparation should preferably fall within the range of 0.00001% by mass to 10% by mass, should more preferably fall within the range of 0.001% by mass to 5% by mass, and should most preferably fall within the range of 0.01% by mass to 1% by mass.
  • the external preparation for skin in accordance with the present invention may embrace cosmetic preparations, pharmaceutical preparations, quasi-drugs, and the like, and may more preferably be applied broadly to the cosmetic preparations.
  • the external preparation for skin in accordance with the present invention may take on an arbitrary preparation form, such as an aqueous solution type, a solubilized type, an emulsion type, an oily liquid type, a gel type, a paste type, an ointment type, an aerosol type, a water-oil two layer type or a water-oil-powder three layer type.
  • the external preparation for skin in accordance with the present invention may take on a form carried by a sheet-shaped base material.
  • the external preparation for skin in accordance with the present invention may take on an arbitrary product form and may be used for an arbitrary use application, such that the effects of the present invention may be achieved.
  • the external preparation for skin in accordance with the present invention may be applied to basic skin care cosmetics, such as a cleansing preparation, a cosmetic lotion, a cosmetic base lotion or cream, a milky lotion, a cream, a gel, an essence (a beauty liquid), a pack, or a mask; a make-up cosmetic preparation, such as a foundation; a sunscreen cosmetic preparation, such as a sunscreen lotion or cream; a body cosmetic preparation, such as a hand lotion or cream, a leg lotion or cream, or a body lotion or cream; or a toiletry product, such as a body soap or a toilet soap.
  • basic skin care cosmetics such as a cleansing preparation, a cosmetic lotion, a cosmetic base lotion or cream, a milky lotion, a cream, a gel, an essence (a beauty liquid), a pack, or a mask
  • the external preparation for skin in accordance with the present invention may be blended appropriately with a different arbitrary constituent ordinarily used in external preparations for skin, such as cosmetic preparations and pharmaceutical preparations, and may be produced by a conventional procedure in accordance with the desired preparation form.
  • the external preparation for skin in accordance with the present invention may be blended appropriately with a whitening agent, a moisturizing agent, an anti-oxidizing agent, an oily constituent, an ultraviolet light absorbing agent, a surface-active agent, a thickening agent, an alcohol, a powder constituent, a coloring agent, an aqueous constituent, water, or a skin nutrient agent.
  • a sequestering agent such as an edetic acid disodium salt, an edetic acid trisodium salt, a sodium citrate, sodium polyphosphate, sodium metaphosphate, or gluconic acid
  • a medicine such as caffeine, tannin, verapamil, tranexamic acid or a derivative thereof, a licorice extract, glabridin, a hot water extract of a fruit of narrow leaf-firethorn ( Pyracantha angustifolia Schneid.), a crude drug, tocopheryl acetate, glycyrrhizinic acid or a derivative thereof or a salt thereof
  • a whitening agent such as vitamin C, magnesium ascorbyl phosphate, ascorbyl glucoside, arbutin, or kojic acid
  • a saccharide such as glucose, fructose, mannose, sucrose, or trehalose.
  • Biodyne EMPP (trademark) (supplied by Arch Personal Care Products L. P.) was employed as the yeast extract
  • Pharcolex Safflower B (supplied by ICHIMARU PHARCOS Co., Ltd.) was employed as the safflower extract.
  • Fibroblasts having been derived from the human newborn foreskin were used as “young fibroblasts”, and fibroblasts having been derived from the derma of the skin of a septuagenarian female were used as “aged fibroblasts”.
  • the fibroblasts were cultured in a 10% FBS-containing DIEM culture medium for 24 hours. Thereafter, the culture medium was replaced by a 0.5% FBS-containing DMEM culture medium, which had been added with 0.1% of a safflower extract, a 0.5% FBS-containing DMEM culture medium, which had been added with 0.01% of a yeast extract, or a 0.5% FBS-containing DMEM culture medium, which had been added with 0.1% of the safflower extract and 0.01% of the yeast extract, and the fibroblasts were cultured still further for 48 hours.
  • a 0.5% FBS-containing DMEM culture medium which had been added with 0.1% of a safflower extract
  • a 0.5% FBS-containing DMEM culture medium which had been added with 0.01% of a yeast extract
  • the fibroblasts were cultured still further for 48 hours.
  • the culture processing was performed in the same manner in a 0.5% FBS-containing DMEM culture medium, which had not been added with the test substance.
  • respiration activity of the fibroblasts was measured by use of an Alamar Blue reagent and was used as an index for the growth of the fibroblasts.
  • a relative fibroblast growth (%) was calculated with respect to the respiration activity of the control, which was taken as 100%.
  • the effect of promoting the growth of the fibroblasts, particularly with respect to the aged fibroblasts, was enhanced synergistically, and the growth of the aged fibroblasts was enhanced to a level equivalent to the level of the growth of the young fibroblasts.
  • the external preparation for skin of each of the examples described above exhibited the excellent effect of improving wrinkles by being applied to the aged skin.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
US12/867,771 2009-03-30 2009-03-30 Agent For Growing Fibroblasts Abandoned US20100316664A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2009/001447 WO2009084742A2 (ja) 2009-03-30 2009-03-30 線維芽細胞増殖剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/001447 A-371-Of-International WO2009084742A2 (ja) 2009-03-30 2009-03-30 線維芽細胞増殖剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/593,683 Division US8628783B2 (en) 2009-03-30 2012-08-24 Method for growing fibroblasts

Publications (1)

Publication Number Publication Date
US20100316664A1 true US20100316664A1 (en) 2010-12-16

Family

ID=40824856

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/867,771 Abandoned US20100316664A1 (en) 2009-03-30 2009-03-30 Agent For Growing Fibroblasts
US13/593,683 Active US8628783B2 (en) 2009-03-30 2012-08-24 Method for growing fibroblasts

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/593,683 Active US8628783B2 (en) 2009-03-30 2012-08-24 Method for growing fibroblasts

Country Status (8)

Country Link
US (2) US20100316664A1 (zh)
EP (1) EP2110123B1 (zh)
JP (1) JP5468906B2 (zh)
KR (1) KR101632265B1 (zh)
CN (1) CN101795668B (zh)
ES (1) ES2569607T3 (zh)
RU (1) RU2492850C2 (zh)
WO (1) WO2009084742A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795640B2 (en) 2011-12-22 2014-08-05 Mary Kay Inc. Lip formulation

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2976490B1 (fr) * 2011-06-20 2013-07-12 Silab Sa Utilisation de substances agissant sur l'igf-1 et/ou l'igf-1r pour leur activite anti-age
EP2540170A1 (de) 2011-06-29 2013-01-02 Evonik Degussa GmbH Dermatologisch wirksamer Hefeextrakt
KR101420211B1 (ko) * 2012-07-03 2014-07-17 (주)바이오시엠 새싹추출물 및 새순추출물을 이용한 피부 외용제 조성물
US10543240B2 (en) 2016-12-12 2020-01-28 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract
WO2018175334A1 (en) 2017-03-20 2018-09-27 Es Biosolutions, Inc. Compositions and methods for skin treatments
JP7241483B2 (ja) * 2018-07-23 2023-03-17 株式会社ノエビア 皮膚用組成物
WO2020021481A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CA3106898A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11045416B2 (en) 2018-08-30 2021-06-29 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and retinol
US11110051B2 (en) 2018-08-30 2021-09-07 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and n-acetyl glucosamine
JP7259157B2 (ja) * 2018-11-05 2023-04-18 共栄化学工業株式会社 皮膚外用剤
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CN111588656B (zh) * 2020-04-30 2021-09-14 杭州谦美化妆品有限公司 一种水解假丝酵母和日本清酒酵母共生发酵产物的用途
JP7225459B1 (ja) 2022-06-01 2023-02-20 株式会社 資生堂 シュワン細胞のアンギオポエチン１（Ａｎｇ－１）分泌を促進するための、ベニバナエキスを含んでなる、組成物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803800A (en) * 1987-03-27 1989-02-14 Plant Genetics, Inc. Synthetic substrate for filamentous fungi
US6207694B1 (en) * 1998-07-27 2001-03-27 Howard Murad Pharmaceutical compositions and methods for managing scalp conditions
US6461857B1 (en) * 2000-07-19 2002-10-08 Arch Personal Care Products, L.P. Producing water-soluble yeast extract by adding peroxide to growing yeast cells
US20040109880A1 (en) * 2001-01-15 2004-06-10 Gilles Pauly Cosmetic and/or pharmaceutical preparations
US20070134265A1 (en) * 2004-03-11 2007-06-14 Shiseido Company, Ltd. Anti-aging composition and collagen production promoting composition
KR20070066452A (ko) * 2005-12-22 2007-06-27 주식회사 코리아나화장품 토마토, 포도, 홍화씨 혼합 초임계 유체 추출물을유효성분으로 함유하는 피부노화 방지용 화장료 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2690352B1 (fr) 1992-04-27 1994-06-10 Marandel Jean Bernard Patin a roulettes a platine inclinee.
JP3213189B2 (ja) * 1994-12-15 2001-10-02 カネボウ株式会社 ヒアルロン酸産生促進剤
JP3748941B2 (ja) 1996-05-01 2006-02-22 株式会社ナリス化粧品 老化防止化粧料
JP3432175B2 (ja) * 1999-04-30 2003-08-04 善三郎 原 細胞増殖促進化粧料
JP3839618B2 (ja) 1999-05-13 2006-11-01 株式会社ノエビア エラスターゼ阻害剤、及びこれを含有して成る老化防止用皮膚外用剤
JP3641699B2 (ja) 2001-05-29 2005-04-27 株式会社ノエビア 皮膚外用剤
JP2003137763A (ja) * 2001-11-01 2003-05-14 Noevir Co Ltd 皮膚外用剤
JP2003342124A (ja) * 2002-05-31 2003-12-03 Noevir Co Ltd 皮膚外用剤
KR100670237B1 (ko) * 2003-11-13 2007-01-17 주식회사 사임당화장품 홍화씨추출물을 함유하는 화장료 조성물 및 홍화씨 내 화장료 유효성분 추출방법
JP3839438B2 (ja) 2004-02-17 2006-11-01 徳雄 陳 アトピー性疾患予防・治療剤
JP2007210915A (ja) * 2006-02-08 2007-08-23 Kose Corp 皮膚外用剤
JP2008184441A (ja) 2007-01-30 2008-08-14 B & C Laboratories Inc 細胞増殖促進用皮膚外用剤
KR101437939B1 (ko) * 2007-04-20 2014-11-03 주식회사 엘지생활건강 주름개선용 화장료 조성물
WO2008151260A2 (en) * 2007-06-04 2008-12-11 Farr Laboratories, Llc Skin care method and kit using peltier thermoelectric device
KR100937339B1 (ko) * 2007-07-20 2010-01-20 주식회사 코리아나화장품 동백꽃, 금은화, 이화, 회화, 백련화, 홍화 및 매화의 혼합 추출물로 구성된 칠화수를 포함하는 피부노화 방지용 화장료 조성물

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803800A (en) * 1987-03-27 1989-02-14 Plant Genetics, Inc. Synthetic substrate for filamentous fungi
US6207694B1 (en) * 1998-07-27 2001-03-27 Howard Murad Pharmaceutical compositions and methods for managing scalp conditions
US6461857B1 (en) * 2000-07-19 2002-10-08 Arch Personal Care Products, L.P. Producing water-soluble yeast extract by adding peroxide to growing yeast cells
US6858212B2 (en) * 2000-07-19 2005-02-22 Arch Personal Care Products, L.P. Water-soluble yeast extract produced by adding peroxide to growing yeast cells
US20040109880A1 (en) * 2001-01-15 2004-06-10 Gilles Pauly Cosmetic and/or pharmaceutical preparations
US20070134265A1 (en) * 2004-03-11 2007-06-14 Shiseido Company, Ltd. Anti-aging composition and collagen production promoting composition
KR20070066452A (ko) * 2005-12-22 2007-06-27 주식회사 코리아나화장품 토마토, 포도, 홍화씨 혼합 초임계 유체 추출물을유효성분으로 함유하는 피부노화 방지용 화장료 조성물

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795640B2 (en) 2011-12-22 2014-08-05 Mary Kay Inc. Lip formulation

Also Published As

Publication number Publication date
EP2110123B1 (en) 2016-03-23
ES2569607T3 (es) 2016-05-11
RU2009128650A (ru) 2011-01-27
JP5468906B2 (ja) 2014-04-09
EP2110123A2 (en) 2009-10-21
WO2009084742A3 (ja) 2009-08-27
KR101632265B1 (ko) 2016-06-21
CN101795668B (zh) 2014-11-05
US8628783B2 (en) 2014-01-14
EP2110123A4 (en) 2012-08-01
RU2492850C2 (ru) 2013-09-20
WO2009084742A2 (ja) 2009-07-09
KR20120041090A (ko) 2012-04-30
JPWO2009084742A1 (ja) 2012-04-05
US20120328648A1 (en) 2012-12-27
CN101795668A (zh) 2010-08-04

Similar Documents

Publication Publication Date Title
US8628783B2 (en) Method for growing fibroblasts
CN110731924B (zh) 增强的抗衰老化妆品组合物
US10350156B2 (en) Method for preparing cosmetic composition containing fermented ginseng berry Pleurotus ferulae product and use thereof
KR101663946B1 (ko) 인삼꽃 흑효모 발효를 통한 진세노사이드 Rg3 강화 및 이를 유효성분으로 함유하는 화장료 조성물
KR101275971B1 (ko) 항산화 활성을 가지는 꽃송이버섯 발효 추출물 및 이를 함유하는 화장료 조성물
KR20150100288A (ko) 흑효모로 발효한 생약추출물을 함유하는 화장료 조성물
KR101855207B1 (ko) 흑효모 발효를 통해 비타민 c 함량이 증가된 카카두플럼 추출물을 함유하는 화장료 조성물
KR101645476B1 (ko) 흑효모 발효를 통해 비타민 c 함량이 증가된 산자나무 발효 추출물을 함유하는 화장료 조성물
KR20150137692A (ko) 홍설차 추출물을 포함하는 화장료 조성물
KR102424510B1 (ko) 락토바실러스 람노서스 j2k-187 균주를 이용한 밀크씨슬 발효 추출물 및 상기 밀크씨슬 발효 추출물을 포함하는 피부 재생과 진정 및 미백용 화장료 조성물
KR20120119520A (ko) 대나무수액의 균발효 추출물을 함유하는 피부외용제 조성물
KR101521239B1 (ko) 황금 붉은덕다리버섯 발효액을 유효성분으로 함유하는 피부 노화 방지 및 피부 주름 개선용 화장료 조성물
KR101545552B1 (ko) 황금 붉은덕다리버섯 발효액을 유효성분으로 함유하는 피부 미백용 화장료 조성물
TWI457144B (zh) Fibroblast proliferator
KR102540595B1 (ko) 귀부균 발효에 의한 포도 열매 추출액의 액상 발효물, 이의 제조방법 및 이를 유효성분으로 포함하는 화장료 조성물
KR102119463B1 (ko) 포제 추출물을 포함하는 조성물
KR101583478B1 (ko) 항자극용 화장료 조성물
KR101521240B1 (ko) 황금 붉은덕다리버섯 발효액을 유효성분으로 함유하는 피부 염증 및 아토피 개선용 화장료 조성물
KR20170065184A (ko) 동충하초 복합 추출물을 함유하는 항산화 화장료 조성물
KR20170140729A (ko) 선복화 추출물의 적합성 시험방법
JP2023031253A (ja) 皮膚外用組成物
KR102073944B1 (ko) 모래밭버섯 자실체 추출물 또는 모래밭버섯 균사체 추출물을 함유하는 피부 외용제 또는 화장료 조성물
KR20230078378A (ko) 에피더미디박테리움 케라티니 추출물이 함침된 다공성 실리카 및 그의 피부상태 개선 용도
KR20130031691A (ko) 망태버섯 추출물을 유효성분으로 포함하는 각질 박리 촉진용 화장료 조성물
CN113230167A (zh) 一种美白组合物、亮肤水及其制备方法

Legal Events

Date Code Title Description
AS Assignment

Owner name: SHISEIDO COMPANY, LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:IINO, MASATO;AMANO, SATOSHI;REEL/FRAME:024839/0621

Effective date: 20100805

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION